To further verify the epigenetic regulatory effects of SLIT2 promoter methylation on the ncRNAs SLIT2-IT1/miR-218, we performed demethylation treatment of the CML cell line K562 with 5-aza-dC. This evidence concerns the gene SLIT2 and chronic myelogenous leukemia, BCR-ABL1 positive.